Chief Compliance Officer and General Counsel · Cano Health, Inc. (CANO)

David Armstrong

A named executive officer of Cano Health in every fiscal year CompBrief holds from FY2020 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,040,551

Salary $235,000Stock awards $687,981

FY2021: $7,714,038

5th of 5 named executive officers at Cano Health by FY2022 total.

5 named officers on file for Cano Health, FY2022

David Armstrong’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • CANO’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cano Health’s whole pay program stands against its peers

  • Cano Health’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CANO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 22, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get David Armstrong’s full pay file as a PDF — free

More than this page: up to 10 years of David’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

David Armstrong compensation by year

Cano Health Summary Compensation Table · all 3 fiscal years held
In US dollars, as Cano Health reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022
Salary$235,000$235,000$235,000
Bonus$70,000$0$0
Stock awards$0$4,800,642$687,981
Option awards$20,880$2,537,958$108,601
Non-equity incentive$0$138,630$0
Pension and deferred compensation$0$0$0
All other$0$1,808$8,969
Total$325,880$7,714,038$1,040,551

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cano Health, Inc. DEF 14A filed May 22, 2023, accession 0001193125-23-149583, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cano Health, Inc. filed document, accession 0001193125-23-149583. Every figure is read from that document and cited to the page and table it appears in. Filed May 22, 2023.

$326K
$7.7M
$1.0M
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU214,000$293,180—
RSU62,737$85,950—
RSU37,500$51,375—
Option27,990—$6.03
Option600,700—$14.75

Per the Outstanding Equity Awards at Fiscal Year-End table in Cano Health, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

7 Form 4 lines since the FY2022 proxy (filed May 22, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-06-28Disposition to the issuer—6,641—0
2023-06-30Grant or award—7,506$0.77664,132
2023-06-06Sale—3,163$1.38656,626
2023-05-31Grant or award—109,526—659,789
2023-03-31Conversion derivative—185,000$0.00689,453
2023-03-31Conversion—185,000$0.00841,626
2023-03-31Conversion derivative—185,000$0.00689,453

The 7 most recent of 7 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments Cano Health discloses, by trigger · FY2022
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$305,500$0$7,410$312,910
Change in control and involuntary termination$540,500$515,020$7,410$1,062,930
Death$0$84,515$0$84,515
Disability$0$84,515$0$84,515

Per the Potential Payments Upon Termination or Change in Control table in Cano Health, Inc.'s FY2022 proxy. Estimates as the company printed them; a dash means it printed no figure.

Cano Health’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Marlow HernandezChief Executive Officer$4,320,007
Robert CamerlinckChief Operating Officer$3,703,685
Brian KoppyChief Financial Officer$1,429,945
Richard AguilarChief Clinical Officer$1,363,834
David Armstrong · this pageChief Compliance Officer and General Counsel$1,040,551

The full Cano Health compensation record

free company brief

This page is one person within Cano Health's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Cano Health proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cano Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Armstrong's compensation dossier · One-time report. No refunds.